The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...

IRVINE, Calif., April 14, 2025--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter ...

Edwards’ INSPIRIS RESILIA and SAPIEN 3 Ultra RESILIA valves are supported by extensive, long-term clinical evidence which is the result of three decades of innovation and expertise, leveraging ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edwards Lifesciences (EW – Research Report) and ...

On Friday, Chief Robert Sapien spoke with ABC7 News about Captain Mark Moalem. "Any time something like this happens, it is frankly devastating internally and externally to the organization ...

Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary ...

Edwards Lifesciences receives CE Mark for Sapien M3 Edwards Lifesciences price target lowered to $75 from $78 at Truist Edwards Lifesciences Hold Rating: Balancing Modest Gains and Market Uncertainty ...